Press releases

SeraNovo and Ildong Pharmaceutical to collaborate on research projects

SeraNovo and Ildong Pharmaceutical to collaborate on research projects

SeraNovo Enters into a multi-compound deal with Ildong Pharmaceutical.

Read more
SeraNovo and Graviton deepen collaboration

SeraNovo and Graviton deepen collaboration

SeraNovo and Graviton deepen collaboration and enter into a second license agreement to develop formulations for Graviton's ROCK-2 inhibitors

Read more
Pharmaceutical product based on SeraNovo’s eutectic formulation technology enters phase I clinical study

Pharmaceutical product based on SeraNovo’s eutectic formulation technology enters phase I clinical study

SeraNovo is proud to announce that in December 2021, Carna Biosciences initiated a clinical study with a drug product based on a joint development program

Read more
SeraNovo Enters into License Agreement with Équilibre BioPharmaceuticals

SeraNovo Enters into License Agreement with Équilibre BioPharmaceuticals

SeraNovo Enters into a License Agreement with Équilibre BioPharmaceuticals

Read more

This website uses cookies to track the usage of it.

More info